The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Weak Pound Boosts FTSE 100; Countrywide Surges 18%

Mon, 07th Dec 2020 08:58

(Alliance News) - Stock prices in London opened mixed on Monday with the internationally exposed FTSE 100 benefiting from weakness in the pound.

M&A news was providing investors with added interest Monday morning, with Countrywide and Elementis, among others, receiving takeover offers.

UK Prime Minister Boris Johnson and European Commission President Ursula von der Leyen will assess whether a post-Brexit trade deal can be salvaged following a weekend of tense negotiations.

The two leaders will speak on Monday evening - their second call in a little over 48 hours - after their top negotiators spent Sunday locked in detailed talks.

David Frost and his EU counterpart Michel Barnier were ordered back to the negotiating table in a final push to see if they could break the stalemate.

However Irish premier Micheal Martin, who has been closely following the talks process, warned that they remained on a "knife-edge". Martin said there appeared to be a "very challenging issue" still to be resolved over the so-called "level playing field" rules on fair competition.

All eyes are on an EU summit on Thursday, with the prospect that any deal - or the failure to find one – will be put to the bloc's 27 leaders at that time. A source close to the talks said the situation was "very difficult" and that negotiations were in their "last useful days".

Without a deal, tariffs would be levied on the huge volumes of trade passing between the UK and the European continent, through the Channel tunnel and by ship, starting on January 1.

The FTSE 100 index was up 10.19 points, or 0.1%, at 6,560.42 early Monday. The mid-cap FTSE 250 index was down 97.12 points, or 0.5%, at 20,085.57. The AIM All-Share index was up 0.4% at 1,072.74.

The Cboe UK 100 index was up 0.1% at 653.35. The Cboe 250 was down 0.5% at 17402.54. The Cboe Small Companies down 0.1% at 11,712.00.

In mainland Europe, the CAC 40 in Paris was down 0.7% while the DAX 30 in Frankfurt was down 0.5% early Monday.

The pound was quoted at USD1.3297 early Monday, sharply lower from USD1.3470 at the London equities close Friday.

At the end of last week, sterling breached the USD1.35 mark, reaching its strongest level since May 2018 on hopes of a Brexit trade agreement. However, cable fell sharply on nervousness over whether a deal will be agreed.

"The Brexit-weakened pound is giving the FTSE a leg up in addition to optimism surrounding the roll out of Pfizer's Covid vaccine which starts this week," said City Index analyst Fiona Cincotta. "The softer tone surrounding the pound is beneficial to multinationals on the FTSE 100 which earn abroad. This accounts for over 70% of the index, boosting it higher."

In the FTSE 100, AstraZeneca was up 2.0% after Morgan Stanley raised the Anglo-Swedish drugmaker to Overweight from Equal Weight. Additionally, on Sunday, AstraZeneca reported ACE-LY-004 phase II trial results, showing efficacy and a steady safety profile for Calquence in mantle cell lymphoma.

At the other end of the large caps, HSBC was down 2.1% after Bank of America downgraded the China-focused lender to Underperform from Neutral.

Elsewhere in London, Countrywide was up 18% at 302.32 pence after the estate agent received an improved offer from peer Connells. Connells offered 325p per share in cash, saying it raised its offer by 30% following discussions with Countrywide's major shareholders.

In response, Countrywide said it will evaluate the merits of the Connells offer but urged shareholders to take no action in the meantime.

Elementis was down 2.1% at 124.10p after the speciality chemicals company said that it received a revised conditional proposal from Minerals Technologies late Friday for a possible cash offer for Elementis at 130 pence per share.

The board of Elementis rejected the offer, saying it was significantly short of a value that would merit engagement and access to the company's non-public information, despite the "continued opportunistic bidding tactics of Minerals Technologies".

The euro was priced at USD1.2111, down from USD1.2140. Against the Japanese yen, the dollar was trading at JPY104.19, flat from JPY104.20.

Brent oil was quoted at USD49.05 a barrel on Monday morning, flat from USD49.08 late Friday. Gold was trading at USD1,838.02 an ounce, up from USD1,832.24.

The Japanese Nikkei 225 index ended down 0.8%. In China, the Shanghai Composite closed down 0.8%, while the Hang Seng index in Hong Kong finished down 1.3%.

Investor sentiment in Asia was hurt by reports that the US is considering fresh sanctions on several Chinese officials over their roles in the disqualification of lawmakers in Hong Kong, as Donald Trump presses ahead with his fight against Beijing before leaving office.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.